Defining Surrogate Endpoints for Clinical Trials in Severe Falciparum Malaria

PLoS ONE - United States
doi 10.1371/journal.pone.0169307
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

A Perspective on Surrogate Endpoints in Controlled Clinical Trials

Statistical Methods in Medical Research
Health Information ManagementEpidemiologyStatisticsProbability
2004English

Surrogate Endpoints in Advanced Sarcoma Trials: A Meta-Analysis

Oncotarget
Oncology
2018English

Prognostic Factors in Severe Falciparum Malaria

Tropical Medicine & Surgery
2014English

Surrogate and Intermediate Endpoints in Randomized Trials: What's the Goal?

Clinical Cancer Research
Cancer ResearchOncology
2018English

Artemether Versus Quinine for Severe Falciparum Malaria

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1996English

Statistical Evaluation of Surrogate Endpoints in Clinical Studies

2014English

Hematological Changes in Severe P. Falciparum Malaria

International Journal of Current Microbiology and Applied Sciences
2017English

Design and Endpoints for Clinical Trials in Primary Sclerosing Cholangitis

Hepatology
MedicineHepatology
2018English

Surrogate Endpoints for Efficacy in Clinical Research: Working Definitions and Validation

AACR Education book
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy